Alexandre Müller
Investor Relations Contact chez MEYER BURGER TECHNOLOGY AG
Postes actifs de Alexandre Müller
Sociétés | Poste | Début | Fin |
---|---|---|---|
MEYER BURGER TECHNOLOGY AG | Investor Relations Contact | - | - |
KARDEX HOLDING AG | Investor Relations Contact | - | - |
Public Communications Contact | - | - | |
Dynamics Group AG
Dynamics Group AG Investment ManagersFinance Dynamics Group AG is an independent Swiss investment research firm which was founded by Franz Egle in 2006. Headquartered in Zurich, the firm offers comprehensive consulting services with a focus on?Corporate Communications, Capital Market Communication, Public Affairs as well as Reputation Management and Crisis Communication. Research and Analysis is supported by a team of 30 financial analysts and market researchers in India. | Analyst-Equity | 26/02/2008 | - |
Historique de carrière de Alexandre Müller
Anciens postes connus de Alexandre Müller
Sociétés | Poste | Début | Fin |
---|---|---|---|
Novo Nordisk Pharma AG
Novo Nordisk Pharma AG Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma AG engages in the research, development, production, and distribution of products for the treatment of diabetes. It also specializes in the areas of obesity, blood coagulation, as well as growth hormones and hormone replacement therapy. The company was founded on February 17, 1930 and is headquartered in Zurich, Switzerland. | Corporate Officer/Principal | - | - |
Bellevue Asset Management AG
Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG. | Gestionnaire de Portefeuille-Actions | 18/04/2011 | - |
Formation de Alexandre Müller
Swiss Federal Institute of Technology | Graduate Degree |
Statistiques
Internationale
Suisse | 7 |
Opérationnelle
Investor Relations Contact | 2 |
Portfolio Manager-Equities | 1 |
Analyst-Equity | 1 |
Sectorielle
Electronic Technology | 3 |
Finance | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
KARDEX HOLDING AG | Electronic Technology |
MEYER BURGER TECHNOLOGY AG | Electronic Technology |
Entreprise privées | 3 |
---|---|
Bellevue Asset Management AG
Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG. | Finance |
Dynamics Group AG
Dynamics Group AG Investment ManagersFinance Dynamics Group AG is an independent Swiss investment research firm which was founded by Franz Egle in 2006. Headquartered in Zurich, the firm offers comprehensive consulting services with a focus on?Corporate Communications, Capital Market Communication, Public Affairs as well as Reputation Management and Crisis Communication. Research and Analysis is supported by a team of 30 financial analysts and market researchers in India. | Finance |
Novo Nordisk Pharma AG
Novo Nordisk Pharma AG Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma AG engages in the research, development, production, and distribution of products for the treatment of diabetes. It also specializes in the areas of obesity, blood coagulation, as well as growth hormones and hormone replacement therapy. The company was founded on February 17, 1930 and is headquartered in Zurich, Switzerland. | Health Technology |
- Bourse
- Insiders
- Alexandre Müller
- Expérience